These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus. Haishi S; Imai H; Hirai K; Igarashi A; Kato S Acta Virol; 1989 Dec; 33(6):497-503. PubMed ID: 2576591 [TBL] [Abstract][Full Text] [Related]
3. High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product. Sato T; Takamura C; Yasuda A; Miyamoto M; Kamogawa K; Yasui K Virology; 1993 Feb; 192(2):483-90. PubMed ID: 8421896 [TBL] [Abstract][Full Text] [Related]
4. Vero cells infected with vaccinia viruses expressing Japanese encephalitis virus envelope protein induce polykaryocyte formation under neutral conditions. Konishi E; Yagawa K; Yamanaka A Jpn J Infect Dis; 2008 Sep; 61(5):410-1. PubMed ID: 18806356 [TBL] [Abstract][Full Text] [Related]
5. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines. NAM JH; BANG HS; CHO HW; CHUNG YH Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219 [TBL] [Abstract][Full Text] [Related]
6. Locus of a virus neutralization epitope on the Japanese encephalitis virus envelope protein determined by use of long PCR-based region-specific random mutagenesis. Morita K; Tadano M; Nakaji S; Kosai K; Mathenge EG; Pandey BD; Hasebe F; Inoue S; Igarashi A Virology; 2001 Sep; 287(2):417-26. PubMed ID: 11531418 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547 [TBL] [Abstract][Full Text] [Related]
8. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206 [TBL] [Abstract][Full Text] [Related]
9. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine. Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388 [TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. Konishi E; Fujii A; Mason PW J Virol; 2001 Mar; 75(5):2204-12. PubMed ID: 11160724 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Yaswen LR; Stephens EB; Davenport LC; Hutt-Fletcher LM Virology; 1993 Aug; 195(2):387-96. PubMed ID: 8393232 [TBL] [Abstract][Full Text] [Related]
12. Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins. Perdiguero B; Blasco R J Virol; 2006 Sep; 80(17):8763-77. PubMed ID: 16912323 [TBL] [Abstract][Full Text] [Related]
13. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus]. Zheng Q; Li P; Cao R; Hou J; Chen P Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695 [TBL] [Abstract][Full Text] [Related]
15. Differential binding efficiency between the envelope protein of Japanese encephalitis virus variants and heparan sulfate on the cell surface. Liu H; Chiou SS; Chen WJ J Med Virol; 2004 Apr; 72(4):618-24. PubMed ID: 14981764 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice. Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432 [TBL] [Abstract][Full Text] [Related]
17. [Expression of human granulocyte-macrophage colony stimulating factor(hGM-CSF) by recombinant vaccinia virus and its effect on immunogenicity]. Liu H; Zhang Z; Yao L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):47-50. PubMed ID: 12515171 [TBL] [Abstract][Full Text] [Related]
18. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Galmiche MC; Goenaga J; Wittek R; Rindisbacher L Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575 [TBL] [Abstract][Full Text] [Related]
19. [Generation of recombinant vaccinia virus expressing attachment glycoprotein of Nipah virus]. Wang XJ; Wang OH; Ge JY; Hu S; Bu ZG Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):644-8. PubMed ID: 17037071 [TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. Konishi E; Yamaoka M; Kurane I; Mason PW Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]